Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

What’s New at the Parker Institute

Dana Farber PICI WHATSNEW Post
Press Releases

Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy

October 16, 2017
CD40 Pancreatic Cancer Trial Graphic Press Release
Press Releases

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

September 20, 2017
UCLA Antoni Ribas Lab
Research Updates

UCLA Study Shows Virus Plus Immunotherapy Hold Promise for Advanced Melanoma

September 7, 2017
More

 The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

Memorial Sloan Kettering Cancer Center
Stanford Medicine
UCLA
UCSF
Penn Medicine
MD Anderson Cancer Center
About Our Model
Parker Institute Parker Institute @parkerici PICI investigator @HowardYChang at @StanfordMed was elected into The National Academy of Medicine @theNAMedicine… https://t.co/LLxqDaSl2F 4 hours ago
Parker Institute Parker Institute @parkerici @DanaFarber Catherine Wu, 1 of 4 @DanaFarber researchers joining us, led this promising study on #cancer… https://t.co/g8Uw2ebRD4 4 hours ago
Parker Institute Parker Institute @parkerici @DanaFarber The new collaboration with @DanaFarber will expand our clinical trials & deepen expertise on cancer… https://t.co/2U2cP7tabZ 7 hours ago

Research Projects

Our investigators collaborate on high-risk, high-reward research projects

Investing in Young Researchers

Training the next generation of scientific leaders in cancer immunotherapy

For Patients

Furthering research to get treatments to patients faster

Our Model

A new approach to accelerate cancer breakthroughs

© 2017 All Rights Reserved
Member Center Login

Get Email Updates